Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Recent Progress in the Intranasal Plga-Based Drug Delivery for Neurodegenerative Diseases Treatment Publisher



Delche NA1 ; Kheiri R2 ; Nejad BG3 ; Sheikhi M4 ; Razavi MS5, 6 ; Rahimzadegan M7 ; Salmasi Z8
Authors

Source: Iranian Journal of Basic Medical Sciences Published:2023


Abstract

One of the most challenging problems of the current treatments of neurodegenerative diseases is related to the permeation and access of most therapeutic agents to the central nervous system (CNS), prevented by the blood-brain barrier (BBB). Recently, intranasal (IN) delivery has opened new prospects because it directly delivers drugs for neurological diseases into the brain via the olfactory route. Recently, PLGA-based nanocarriers have attracted a lot of interest for IN delivery of drugs. This review gathered clear and concise statements of the recent progress of the various developed PLGA-based nanocarriers for IN drug delivery in brain diseases including Alzheimer’s, Parkinson’s, brain tumors, ischemia, epilepsy, depression, and schizophrenia. Subsequently, future perspectives and challenges of PLGA-based IN administration are discussed briefly. © 2023 Mashhad University of Medical Sciences. All rights reserved.
Other Related Docs
14. Vip-Loaded Plga As an Anti-Asthma Nanodrug Candidate, Comparative Clinical Pathology (2016)
16. Lipid-Based Nanoparticles for Drug Delivery Systems, Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (2018)
17. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
20. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)